secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001104659-22-129900
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva repurchases 720k shares from subsidiary founders at $0.4001/share for $288k
--------------------------------------------------------------------------------

- Repurchased 720,000 shares from three founders (Manel Maria Cascallo Piqueras, Ramon Alemany, Gabriel Maria Capella Minar) at $0.4001 per share.
- Aggregate purchase price of $288,072; funded from cash on hand; shares will be held as treasury stock.
- Selling stockholders originally acquired shares as consideration for sale of subsidiary to Theriva in March 2022.
- Transaction privately negotiated; not part of a broader buyback program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465922129900/0001104659-22-129900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465922129900/tm2233416d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-129900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer